How Sensitive Is Pfizer To R&D Expense Changes?

We estimate that Pfizer's (NYSE:PFE) R&D expenses will grow in low single digits to $7.8 billion in 2018. However, we expect a slight decline in R&D expenditure as a percentage of Pfizer's gross profit. Of late, many large pharmaceutical firms are becoming more financially disciplined in order...